Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANPA | Rich Sparkle | $19.50 | -$7.05 | -26.55% | 6.8K | $331.9M | $2.80$54.75 |
| IMPP | Imperial Petroleum | $4.72 | -$1.29 | -21.42% | 2M | $209.1M | $2.12$6.57 |
| SGBX | Safe & Green | $3.39 | -$0.51 | -13.03% | 1.1M | $22.2M | $1.81$122.88 |
| AGCC | Agencia Comercial Spirits | $6.25 | -$0.92 | -12.83% | 46.9K | $244.6M | $3.66$8.25 |
| NEPH | Nephros | $4.86 | -$0.55 | -10.17% | 37.4K | $57.5M | $1.39$6.42 |
| ATLN | Atlantic International | $2.05 | -$0.22 | -9.69% | 235 | $132.9M | $1.45$7.97 |
| WALD | Waldencast Plc | $2.38 | -$0.25 | -9.51% | 1.4K | $294.7M | $1.48$4.18 |
| NDRA | Endra Life Sciences | $5.64 | -$0.59 | -9.47% | 13.2K | $7.3M | $2.90$11.96 |
| SPPL | Simpple | $3.50 | -$0.35 | -9.13% | 965 | $18.8M | $2.18$16.80 |
| AFJK | Aimei Health Technology | $10.65 | -$1.05 | -8.97% | 12.6K | $71.6M | $9.50$41.80 |
Related Articles
Featured Article
This Fitness Tech Stock Has Crushed Apple's 2025 Gains -- 1 Reason Why
Lyle Daly|Oct 19, 2025
The Amazfit brand has helped Zepp Health bounce back in a big way after years of negative returns.
Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround
Alex Carchidi|Jun 12, 2023
Ironwood's plan to purchase a smaller biotech should address some issues that have shareholders concerned.
Is Arrowhead Pharmaceuticals a Buy Now?
Cory Renauer|Apr 16, 2023
The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.
2 Biotech Stocks That Could Soar by 130% and 92%, According to Wall Street
George Budwell, PhD|Apr 4, 2023
Arrowhead Pharmaceuticals and Seres Therapeutics are screaming buys, according to some Wall Street analysts.
3 No-Brainer Stocks to Buy Right Now for Less Than $25
James Halley|Feb 4, 2023
All three healthcare stocks are showing solid long-term potential.
3 Biotech Stocks That Could Go Parabolic in 2022
George Budwell, PhD|Jan 17, 2022
Arrowhead Pharmaceuticals, Madrigal Pharmaceuticals, and Viking Therapeutics could be big winners this year.
4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout
Cory Renauer|Nov 23, 2021
The recent acquisition of Dicerna Pharmaceuticals makes Arrowhead Pharmaceuticals look like the next biotech in line to receive a juicy buyout offer.
Arrowhead Pharmaceuticals: Buy the Dip?
Zhiyuan Sun|Jul 19, 2021
This biotech underdog offers more than meets the eye.
2 Monster Young Biotech Stocks to Add to Your Watchlist
Alex Carchidi|Oct 31, 2020
These biotechs are fueling up for massive market launches.
3 Great Stocks Under $10
Will Healy|Sep 27, 2020
These stocks hold tremendous potential despite a low price.
